Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gil Zandani"'
Autor:
Sarit Anavi-Cohen, Nina Tsybina-Shimshilashvili, Gil Zandani, Ran Hovav, Noa Sela, Abraham Nyska, Zecharia Madar
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
This study aimed to investigate the effects of two types of peanuts, regular Hanoch (HN) and a new high-oleic cultivar., Hanoch-Oleic (HO), on metabolic parameters and gut microbiota composition. Male C57BL/6 mice were fed with a normal diet (ND) or
Externí odkaz:
https://doaj.org/article/12a57eecb9044c68b93b94df94dce3f0
Autor:
Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, Anna Altberg, Noa Sela, Abraham Nyska, Zecharia Madar
Publikováno v:
Journal of Cannabis Research, Vol 4, Iss 1, Pp 1-13 (2022)
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several studies in mice and humans have implicated the involvement of the gut microbiome in
Externí odkaz:
https://doaj.org/article/fa1e3b706cf3437cbed0e3898c23e522
Autor:
Sarit Anavi-Cohen, Gil Zandani, Nina Tsybina-Shimshilashvili, Ran Hovav, Noa Sela, Abraham Nyska, Zecharia Madar
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
A new Israeli-developed peanut cultivar, “Hanoch-Oleic” (HO), uniquely contains enlarged oleic acid contents and was designed to confer additional beneficial effects over the traditional cultivar, “Hanoch” (HN). This work elucidates metabolic
Externí odkaz:
https://doaj.org/article/26fa6a73a0544db09b8ddaa1fd64cc15
Autor:
Gil Zandani, Sarit Anavi-Cohen, Tamar Yudelevich, Abraham Nyska, Nativ Dudai, Zecharia Madar, Jonathan Gorelick
Publikováno v:
Nutrients, Vol 14, Iss 21, p 4552 (2022)
Non-alcoholic fatty liver disease (NAFLD) has become an epidemic with increasing prevalence. Limited treatment options and poor adherence emphasize the urgent need for novel therapies for the treatment and/or prevention of NAFLD. Bioactive natural co
Externí odkaz:
https://doaj.org/article/65e4fc37743c4e94ad794699b6f7652f
Autor:
Gil Zandani, Sarit Anavi-Cohen, Nina Tsybina-Shimshilashvili, Noa Sela, Abraham Nyska, Zecharia Madar
Publikováno v:
Frontiers in Nutrition, Vol 8 (2021)
Nonalcoholic fatty liver disease (NAFLD) is linked to obesity, type 2 diabetes, hyperlipidemia, and gut dysbiosis. Gut microbiota profoundly affects the host energy homeostasis, which, in turn, is affected by a high-fat diet (HFD) through the liver-g
Externí odkaz:
https://doaj.org/article/f0bfab6d788946dc8c85d7472ac4145c
Autor:
Gil Zandani, Sarit Anavi-Cohen, Tal Assa-Glazer, Jonathan Gorelick, Abraham Nyska, Noa Sela, Nirit Bernstein, Zecharia Madar
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2022:1-13
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver abnormalities and has been linked with metabolic syndrome hallmarks. Unfortunately, current treatments are limited. This work aimed to elucidate the effects of three cannabis
Publikováno v:
Toxicologic Pathology. 48:702-707
Quantification of fatty vacuoles in the liver, with differentiation from lumina of liver blood vessels and bile ducts, is an example where the traditional semiquantitative pathology assessment can be enhanced with artificial intelligence (AI) algorit
Publikováno v:
Food & Nutrition Research.
Background: Nonalcoholic fatty-liver disease (NAFLD) is a global health problem associated with gut dysbiosis and intestinal permeability. Broccoli is a natural source of bioactive phytochemicals, characterized by health-promoting properties. Objecti
Autor:
Nina Tsybina-Shimshilashvili, Abraham Nyska, Gil Zandani, Noa Sela, Sarit Anavi-Cohen, Zecharia Madar
Publikováno v:
Frontiers in Nutrition
Frontiers in Nutrition, Vol 8 (2021)
Frontiers in Nutrition, Vol 8 (2021)
Nonalcoholic fatty liver disease (NAFLD) is linked to obesity, type 2 diabetes, hyperlipidemia, and gut dysbiosis. Gut microbiota profoundly affects the host energy homeostasis, which, in turn, is affected by a high-fat diet (HFD) through the liver-g
Autor:
Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, Anna Altberg, Noa Sela, Abraham Nyska, Zecharia Madar
Publikováno v:
Journal of cannabis research. 4(1)
Background Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several studies in mice and humans have implicated the involvement of the gut microbiome in NAFLD. Wh